PASOTUXIZUMAB
UNII 9J6SW7G28J

Substance Identification & Data

This profile provides standardized clinical and technical data for Pasotuxizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9J6SW7G28J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1442657-12-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9J6SW7G28J

CAS Registry Number

1442657-12-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PASOTUXIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C103827

National Cancer Institute reference terminology for clinical and research data.

INN ID

9937

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pasotuxizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PASOTUXIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN SCFV-SCFV, ANTI-(HOMO SAPIENS FOLH1 (FOLATE HYDROLASE, PROSTATE SPECIFIC MEMBRANE ANTIGEN, PSMA))/ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY BISPECIFIC SINGLE CHAIN

PASOTUXIZUMAB [INN]

PASOTUXIZUMAB [WHO-DD]

External Clinical & Regulatory Resources

Previous UNII9J6QGP7WEA

Next UNII9J727K8R3U